Group One Trading, L.P. 180 Life Sciences Corp. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$0.12 - $1.31 $1,852 - $20,225	15,439 Added 130.67%	27,254 $19,000
Q2 2022 Aug 11, 2022	BUY	$0.81 - $2.53 $9,570 - $29,891	11,815 New	11,815 $10,000
Q1 2022 May 12, 2022	SELL	$2.53 - $3.9 $70,999 - $109,445	-28,063 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$3.27 - $6.38 $178,865 - $348,979	-54,699 Reduced 66.09%	28,063 $109,000
Q3 2021 Nov 12, 2021	BUY	$5.11 - $10.81 $422,913 - $894,657	82,762 New	82,762 $448,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $141M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.